ロード中...
Efficacy and Safety of Canagliflozin in Kidney Transplant Patients
INTRODUCTION: There is no report of efficacy and safety of canagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor in post kidney transplant patients with diabetes. MATERIALS AND METHODS: A pilot study was undertaken in stable renal transplant recipients with preexisting diabetes or new on...
保存先:
| 出版年: | Indian J Nephrol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer - Medknow
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6668319/ https://ncbi.nlm.nih.gov/pubmed/31423063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijn.IJN_2_18 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|